Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 438,180 | 1,568,040 | 1,395,820 | 970,340 | 300,780 |
| Depreciation Amortization | 0 | 553,280 | 0 | 0 | 0 |
| Other Working Capital | -37,380 | -189,520 | -318,380 | -363,990 | -10,560 |
| Other Operating Activity | 216,270 | -94,200 | 308,020 | 115,650 | 158,750 |
| Operating Cash Flow | $617,070 | $1,837,600 | $1,385,460 | $722,000 | $448,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43,010 | -417,310 | -286,560 | -172,310 | -78,140 |
| Net Acquisitions | 0 | -10,850 | 0 | 0 | 0 |
| Other Investing Activity | -11,460 | 149,220 | -22,760 | -19,360 | -530 |
| Investing Cash Flow | $-54,470 | $-278,940 | $-309,320 | $-191,670 | $-78,670 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | -408,660 | 0 | 0 | 0 |
| Other Financing Activity | -677,570 | -848,610 | -878,010 | -384,440 | -371,530 |
| Financing Cash Flow | $-677,570 | $-1,257,270 | $-878,010 | $-384,440 | $-371,530 |
| Exchange Rate Effect | -4,620 | -1,100 | -180 | -3,430 | -880 |
| Beginning Cash Position | 928,010 | 549,240 | 552,220 | 540,280 | 525,360 |
| End Cash Position | 808,420 | 849,520 | 750,170 | 682,730 | 523,240 |
| Net Cash Flow | $-119,590 | $300,280 | $197,950 | $142,440 | $-2,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | 617,070 | 1,837,600 | 1,385,460 | 722,000 | 448,970 |
| Free Cash Flow | 617,070 | 1,837,600 | 1,385,460 | 722,000 | 448,970 |